UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Mar. 31, 2025 |
Mar. 31, 2024 |
Mar. 31, 2025 |
Mar. 31, 2024 |
|
| UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME | ||||
| Revenues from contracts with customers | $ 59,596,050 | $ 84,038,761 | $ 258,976,239 | $ 340,515,393 |
| Initial recognition and changes in the fair value of biological assets at the point of harvest | 990,940 | (56,756) | 1,578,993 | 281,372 |
| Cost of sales | (36,738,969) | (41,337,736) | (154,085,421) | (201,664,054) |
| Changes in the net realizable value of agricultural products after harvest | (218,205) | 170,811 | (423,115) | (2,021,747) |
| Research and development expenses | (3,659,747) | (3,590,101) | (12,263,862) | (11,814,419) |
| Selling, general and administrative expenses | (26,153,159) | (27,089,241) | (89,478,363) | (92,187,026) |
| Share of profit or loss of joint ventures and associates | (943,603) | 906,136 | (1,169,766) | 4,467,103 |
| Other income or expenses, net | 8,059,903 | 158,946 | 8,085,743 | (2,239,292) |
| Operating profit | 933,210 | 13,200,820 | 11,220,448 | 35,337,330 |
| Financial cost | (6,106,655) | (7,235,352) | (20,700,288) | (18,713,202) |
| Other financial results | (423,673) | 2,856,009 | (3,175,591) | (480,187) |
| Profit/ (Loss) before income tax | (5,597,118) | 8,821,477 | (12,655,431) | 16,143,941 |
| Income tax | 4,006,054 | 955,832 | 5,471,555 | (7,806,595) |
| Profit/ (Loss) for the period | (1,591,064) | 9,777,309 | (7,183,876) | 8,337,346 |
| Profit (Loss) for the period attributable to: | ||||
| Equity holders of the parent | (1,303,923) | 9,257,226 | (7,529,650) | 4,774,041 |
| Non-controlling interests | (287,141) | 520,083 | 345,774 | 3,563,305 |
| Profit/ (Loss) for the period | $ (1,591,064) | $ 9,777,309 | $ (7,183,876) | $ 8,337,346 |
| Profit/ (Loss) per share | ||||
| Basic loss attributable to ordinary equity holders of the parent | $ (0.0208) | $ 0.1473 | $ (0.1199) | $ 0.076 |
| Diluted loss attributable to ordinary equity holders of the parent | $ (0.0208) | $ 0.1387 | $ (0.1199) | $ 0.0715 |
| Profit/ (Loss) for the period | $ (1,591,064) | $ 9,777,309 | $ (7,183,876) | $ 8,337,346 |
| Other comprehensive profit/ (loss) | (788,930) | 193,599 | (705,969) | (250,655) |
| Items that may be subsequently reclassified to profit/(loss) | (788,930) | 193,599 | (705,969) | (250,655) |
| Foreign exchange differences on translation of foreign operations from joint ventures | (1,136) | (239) | ||
| Foreign exchange differences on translation of foreign operations | (788,930) | 194,735 | (705,969) | (250,416) |
| Total comprehensive profit/ (loss) | (2,379,994) | 9,970,908 | (7,889,845) | 8,086,691 |
| Total comprehensive profit/ (loss) attributable to: | ||||
| Equity holders of the parent | (2,121,169) | 9,492,441 | (8,142,223) | 4,639,087 |
| Non-controlling interests | (258,825) | 478,467 | 252,378 | 3,447,604 |
| Total comprehensive profit/ (loss) | $ (2,379,994) | $ 9,970,908 | $ (7,889,845) | $ 8,086,691 |
| X | ||||||||||
- Definition Change in the net realizable value of agricultural. No definition available.
|
| X | ||||||||||
- Definition The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of income or cost associated with interest and other financing activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, net of tax, before reclassification adjustments. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The gains (losses) arising from changes in fair value less costs to sell of biological assets due to both physical and price changes in the market. [Refer: Biological assets] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of other comprehensive income, net of tax, related to exchange differences on translation of the financial statements of a parent company or a stand-alone entity to a different presentation currency. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of finance income or cost that the entity does not separately disclose in the same statement or note. [Refer: Finance income (cost)] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of operating income (expense) that the entity does not separately disclose in the same statement or note. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The profit (loss) before tax expense or income. [Refer: Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The profit (loss) from operating activities of the entity. [Refer: Profit (loss)] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of expenditure directly attributable to research or development activities, recognised in profit or loss. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity’s ordinary activities in exchange for consideration. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of expense relating to selling, general and administrative activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Total for all associates [member]; Investments accounted for using equity method; Total for all joint ventures [member]; Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|